Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan

BACKGROUND: Smoking cessation pharmacotherapies (SCPs) have been established as cost-effective for the treatment of tobacco use disorder across a variety of settings. In Jordan, a resource-constrained country where smoking rates rank at one of the highest globally, the cost-effectiveness of SCPs has...

Descripción completa

Detalles Bibliográficos
Autores principales: Madae’en, Saba, Obeidat, Nour, Adeinat, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Policy Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590594/
https://www.ncbi.nlm.nih.gov/pubmed/33117544
http://dx.doi.org/10.1186/s40545-020-00270-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590594/
https://www.ncbi.nlm.nih.gov/pubmed/33117544
http://dx.doi.org/10.1186/s40545-020-00270-y

Ejemplares similares